Latest Blog Posts
Search
Sort Results
Filter by Specific Population
Filter by Topic
Filter by Infection
- HIV (remove)
Filter by Resource Category
- Research summary (remove)
Search results
Current filters: HIV, Treatment, Research summary, HIV drugs, Drug treatment strategies
23 search results
- Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Dovato (dolutegravir + 3TC) in initial HIV treatment
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Can high-dose dolutegravir be a rescue therapy?
-
From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage - De-simplifying single-tablet regimens for HIV treatment
-
2019, CATIE
Research summary - Webpage - Italian study explores dual drug regimens as maintenance treatment
-
From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage - Dual maintenance therapy with dolutegravir + rilpivirine
-
From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage - Dolutegravir + 3TC for the initial treatment of HIV
-
From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage - Switching from Triumeq to Biktarvy
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Switching to Biktarvy from a protease inhibitor–based regimen
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Winnipeg doctors use dolutegravir and darunavir for simplifying treatment
-
2018, CATIE
Research summary - Webpage
